Urgent search for safe and effective treatments of severe acute respiratory syndrome: Is melatonin a promising candidate drug?

Journal of Pineal Research

Volumn 35, Issue 1, 2003, Pages 69-70

  Shiu, Stephen Y W ^a   Reiter, Russel J ^b   Tan, Dun Xian ^b   Pang, Shiu F ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CK Life Sciences Int'l Holdings Inc   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ANTIOXIDANT; ANTIVIRUS AGENT; MELATONIN; RIBAVIRIN; STEROID; VACCINE;

CHINA; CORONAVIRUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL DISEASE; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; MORTALITY; NONHUMAN; NOTE; PNEUMONIA; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; MELATONIN; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0037670863     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2003.00068.x     Document Type: Note

References (24)

1. DROSTEN C, GUNTHER S, PREISER W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; April 10: http://www.nejm.org.
2. KSIAZEK TG, ERDMAN D, GOLDSMITH CS et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; April 10: http://www.nejm.org.
3. PEIRIS J, LAI S, POON L et al. Coronarvirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-1325.
4. LEE N, HUI D, WU A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; April 7: http://www.nejm.org.
5. POUTANEN SM, LOW DE, HENRY B et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; Mar 31: http://www.nejm.org.
6. TSANG KW, HO PL, OOI GC et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; Mar 31: http://www.nejm.org.
7. CHAN-YEUNG M, YU WC. Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report. BMJ 2003; 326:850-852.
8. ZHANG H, SLUTSKY AS, VINCENT JL. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Inten Care Med 2000; 26:474-476.
9. BOUHAFS RK, JARSTRAND C. Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res 2002; 36:727-734
10. CELIK H, AYAR A, TUG N et al. Effects of melatonin on noncardiogenic pulmonary edema secondary to adnexial ischemia-reperfusion in guinea pig. Neuroendocrinol Lett 2002; 23:115-118.
11. INCI I, INCI D, DUTLY A, BOEHLER A, WEDER W. Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann Thorac Surg 2002; 73:220-225.
12. BERNARD GR, WHEELER AP, ARONS MM et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidants in ARDS Study Group. Chest 1997; 112:164-172.
13. TAN DX, MANCHESTER LC, HARDELAND R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res. 2003; 34:75-78.
14. TAN DX, CHEN LD, POEGGELER B, MANCHESTER LC, REITER RJ. Melatonin: a potent, endogenous hydroxyl rdical scavenger. Endocr J 1993; 1:57-60.
15. CUZZOCREA S, REITER RJ. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002; 2:153-165.
16. BONILLA E, RODON C, VALERO N et al. Melatonin prolongs survival of immunodepressed mice infected with the Venezuelan equine encephalomyelitis virus. Trans R Soc Trop Med Hyg 2001; 95:207-210.
17. BONILLA E, VALERO-FUENMAYOR N, PONS H, CHACIN-BONILLA U. Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Cell Mol Life Sci 1997; 53:430-434.
18. ELLIS LC. Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J Pineal Res 1996; 21:214-217.
19. CUZZOCREA S, TAN DX, COSTANTINO G, MAZZON E, CAPUTI AP, REITER RJ. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J 1999; 13:1930-1938.
20. FULIA F, GITTO E, CUZZOCREA S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31:343-349.
21. GITTO E, KARBOWNIK M, REITER RJ et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50:756-760.
22. AOYAMA H, MORI W, MORI N. Anti-glucocorticoid effects of melatonin in young rats. Acta Pathol Jpn 1986; 36:423-428.
23. SAINZ RM, MAYO JC, REITER RJ, ANTOLIN I, ESTEBAN MM, RODRIGUEZ C. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J 1999; 13:1547-1556.
24. REITER RJ, TAN DX, SAINZ RM, MAYO JC, LOPEZ-BURILLO S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54:1299-1321.